Anthony Doyle - Net Worth and Insider Trading
Anthony Doyle Net Worth
The estimated net worth of Anthony Doyle is at least $2 Million dollars as of 2024-12-26. Anthony Doyle is the CFO of BioCryst Pharmaceuticals Inc and owns about 266,744 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $2 Million. Details can be seen in Anthony Doyle's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Anthony Doyle has not made any transactions after 2024-05-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Anthony Doyle
Anthony Doyle Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Anthony Doyle owns 1 companies in total, including BioCryst Pharmaceuticals Inc (BCRX) .
Click here to see the complete history of Anthony Doyle’s form 4 insider trades.
Insider Ownership Summary of Anthony Doyle
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2024-05-14 | Chief Financial Officer |
Anthony Doyle Latest Holdings Summary
Anthony Doyle currently owns a total of 1 stock. Anthony Doyle owns 266,744 shares of BioCryst Pharmaceuticals Inc (BCRX) as of May 14, 2024, with a value of $2 Million.
Latest Holdings of Anthony Doyle
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2024-05-14 | 266,744 | 7.72 | 2,059,264 |
Holding Weightings of Anthony Doyle
Anthony Doyle Form 4 Trading Tracker
According to the SEC Form 4 filings, Anthony Doyle has made a total of 4 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years, including 3 buys and 1 sells. The most-recent trade in BioCryst Pharmaceuticals Inc is the acquisition of 36,300 shares on May 14, 2024, which cost Anthony Doyle around $202,191.
Insider Trading History of Anthony Doyle
- 1
Anthony Doyle Trading Performance
GuruFocus tracks the stock performance after each of Anthony Doyle's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Anthony Doyle is 29.74%. GuruFocus also compares Anthony Doyle's trading performance to market benchmark return within the same time period. The performance of stocks bought by Anthony Doyle within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Anthony Doyle's insider trading performs compared to the benchmark.
Performance of Anthony Doyle
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.61 | | | | | |
| Relative Return to S&P 500(%) | 6.12 | | | | | |
Anthony Doyle Ownership Network
Anthony Doyle Owned Company Details
What does BioCryst Pharmaceuticals Inc do?
Who are the key executives at BioCryst Pharmaceuticals Inc?
Anthony Doyle is the Chief Financial Officer of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include Vice President and CCO Charles K Gayer , VP & General Counsel & Corp Sec Alane P Barnes , and director & CEO Jon P Stonehouse .
BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary
Over the past 18 months, Anthony Doyle made 1 insider transaction in BioCryst Pharmaceuticals Inc (BCRX) with a net purchase of 36,300. Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 2,000 shares made by Nancy J Hutson , a net purchase of 30,000 shares made by Jon P Stonehouse , and a net purchase of 30,000 shares made by Helen M. Thackray .
In summary, during the past 3 months, insiders sold 7,000 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 7,000 shares. During the past 18 months, 26,987 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 183,601 shares were bought by its insiders, resulting in a net purchase of 156,614 shares.
BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioCryst Pharmaceuticals Inc Insider Transactions
Anthony Doyle Mailing Address
Above is the net worth, insider trading, and ownership report for Anthony Doyle. You might contact Anthony Doyle via mailing address: 4505 Emperor Blvd., Suite 200, Durham Nc 27703.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
